1. Home
  2. BZH vs DNA Comparison

BZH vs DNA Comparison

Compare BZH & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$24.06

Market Cap

672.0M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$6.75

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
DNA
Founded
1985
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.0M
607.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
BZH
DNA
Price
$24.06
$6.75
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$32.00
$10.50
AVG Volume (30 Days)
513.4K
1.2M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,087,739,000.00
N/A
Revenue This Year
$8.45
N/A
Revenue Next Year
$12.21
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.37
$5.00
52 Week High
$28.33
$17.58

Technical Indicators

Market Signals
Indicator
BZH
DNA
Relative Strength Index (RSI) 40.53 35.40
Support Level $20.08 $6.54
Resistance Level $24.22 $10.05
Average True Range (ATR) 0.89 0.67
MACD -0.43 -0.27
Stochastic Oscillator 18.81 11.06

Price Performance

Historical Comparison
BZH
DNA

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: